Tofavit Tablets 5 mg by Oriox Pharmaceuticals contain Tofacitinib, a selective Janus Kinase (JAK) inhibitor used in the treatment of various autoimmune and inflammatory disorders. By targeting specific pathways involved in the immune response, Tofacitinib helps regulate inflammation and supports disease management in eligible patients.

Manufactured to high pharmaceutical quality standards, Tofavit Tablets provide a convenient oral treatment option with consistent dosing and reliable efficacy. The tablet formulation is designed for ease of administration and may be prescribed as part of a comprehensive treatment plan based on individual patient needs.

Tofavit should be used strictly under medical supervision, with dosage and duration determined by a healthcare professional. Regular monitoring may be required during treatment to ensure optimal therapeutic outcomes and patient safety.

Key Features

• Contains Tofacitinib I.P. 5 mg
• Oral JAK inhibitor therapy
• Helps manage immune-mediated inflammatory conditions
• Convenient tablet dosage form
• Manufactured under stringent quality standards
• Suitable for prescribed long-term therapy
• Reliable and consistent formulation
• Packaged for patient convenience

Pack Size

10 × 10 Tablets

⚠️ Prescription Medication – To Be Used Only Under Medical Supervision